Regarding specific cancer-associated genes, the CYT-high subgroup had more CNAs, including gains in NF1, CDK12, ERBB2, RARA, MDM4 and MYC; and losses in BRCA1, CD274 and APC. This evidence concerns the gene ERBB2 and cancer.